Paper Details

  1. Home
  2. Paper Details

Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.

Author:

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Short-course chemotherapy with rifampicin plus isoniazid for 9 months, supplemented by ethambutol for the first 2 months, was highly effective in treating tuberculosis and had a lower relapse rate than longer regimens.
Paper Details　
Original Abstract of the Article :
The results of short courses of chemotherapy using rifampicin plus isoniazid, supplemented for the first two months by streptomycin or ethambutol, in patients with newly diagnosed pulmonary tuberculosis, have been studied. 174 patients with little or no cavitation received six months chemotherapy. 1...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/46047

データ提供：米国国立医学図書館（NLM）

Short-Course Chemotherapy for Pulmonary Tuberculosis

Pulmonary tuberculosis, a condition that can feel like a persistent cough that won't quit, can be a challenging experience. This study investigates the effectiveness of short-course chemotherapy, a new approach to treating tuberculosis, compared to traditional longer courses. The researchers found that short-course chemotherapy, using a combination of medications, was just as effective as standard long-course treatment in clearing the infection and preventing relapses. This suggests that short-course chemotherapy could be a more convenient and potentially less burdensome option for patients with tuberculosis.

Short-Course Chemotherapy: A Quicker Route Through the Desert of Tuberculosis

This study offers a quicker route through the desert of tuberculosis, demonstrating the effectiveness of short-course chemotherapy in eradicating the infection and preventing relapses. It highlights the potential for this approach to improve the lives of those living with tuberculosis by reducing the duration of treatment and minimizing potential side effects.

Navigating the Desert of Tuberculosis

This research underscores the importance of finding the right treatment for tuberculosis. It reminds us that there are new and potentially more effective options available, and that working with a doctor to find the best approach for our individual needs is crucial. Just as a desert traveler might seek a shortcut to reach their destination, we need to explore new approaches to manage our health effectively.

Dr. Camel's Conclusion

This study provides a valuable insight into the potential of short-course chemotherapy as a more convenient and effective option for treating pulmonary tuberculosis. Just as a desert traveler seeks a direct path to their oasis, this approach offers a quicker route through the desert of tuberculosis, leading to faster recovery and improved well-being.
Date :
  1. Date Completed 1975-04-23
  2. Date Revised 2015-06-16
Further Info :

Pubmed ID

46047

DOI: Digital Object Identifier

S0140-6736(75)91426-9

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.